N | n | Prev | cOR | CI 95 % | aORa | CI 95 % | AFp(%) | |
---|---|---|---|---|---|---|---|---|
MEN | ||||||||
IMC | ||||||||
18.5–24.9 | 749 | 73 | 9.75 | 1 | 1 | 26.19 | ||
25–29.9 | 849 | 113 | 13.31 | 1.42 | 1.04–1.94 | 1.13 | 0.80–1.58 | |
30–34,9 | 328 | 79 | 24.09 | 2.94 | 2.07– 4.17 | 2.37 | 1.62–3.48 | |
35–39.9 | 74 | 21 | 28.38 | 2.97 | 1.80–4.92 | 3.19 | 1.83–5.55 | |
≥40 | 33 | 5 | 15.15 | |||||
CUN-BAE | ||||||||
≤19.9 | 258 | 9 | 3.49 | 1 | 1 | 71.54 | ||
20–24.9 | 521 | 35 | 6.72 | 1.99 | 0.94–4.21 | 1.66 | 0.78–3.55 | |
25–29.9 | 631 | 95 | 15.06 | 4.90 | 2.44–9.87 | 3.49 | 1.70–7.16 | |
30–34.9 | 415 | 87 | 20.96 | 7.34 | 3.62–14.86 | 4.91 | 2.37–10.14 | |
≥35 | 208 | 65 | 31.25 | 12.58 | 6.08–26.01 | 8.34 | 3.96–17.56 | |
WOMEN | ||||||||
IMC | ||||||||
18.5–24.9 | 895 | 50 | 5.59 | 1 | 1 | 40.38 | ||
25–29.9 | 565 | 76 | 13.45 | 2.63 | 1.81–3.82 | 1.78 | 1.20–2.64 | |
30–34,9 | 259 | 45 | 17.37 | 3.55 | 2.31–5.46 | 2.09 | 1.33–3.31 | |
35–39.9 | 86 | 21 | 24.42 | 5.46 | 3.09–9.64 | 3.44 | 1.86–6.35 | |
≥40 | 50 | 19 | 38,0 | 10.36 | 5.47–19.61 | 8.13 | 4.08–16.18 | |
CUN-BAE | ||||||||
≤29.9 | 303 | 10 | 3.3 | 1 | 1 | 65.19 | ||
30–34.9 | 402 | 23 | 5.72 | 1.78 | 0.83–3.79 | 1.64 | 0.76–3.54 | |
35–39.9 | 464 | 36 | 7.76 | 2.46 | 1.20–5.04 | 1.86 | 0.89–3.87 | |
40–44.9 | 389 | 61 | 15.68 | 5.45 | 2.74–10.83 | 3.47 | 1.69–7.13 | |
≥45 | 297 | 81 | 27.27 | 10.99 | 5.57–21.69 | 6.49 | 3.16–13.3 |